NCT06018857Active, not recruiting
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
Source: ClinicalTrials.gov · Last updated 6 Mar 2026
Brief summary (registry, in English)
This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 24 Aug 2023
- Start date
- 11 May 2017
- Primary completion date
- Dec 2028
- Lead sponsor
- Federico Aucejo
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06018857
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 11 May 2017 to the primary completion date, Dec 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients who have hepatocellular carcinoma but do not undergo liver transplantation
Age
- Patients under 18 years old
Other
- Patients who do not have hepatocellular carcinoma
Who the study is looking for
- Adult patients (age\>18 years) undergoing Liver transplant for hepatocellular carcinoma
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cleveland Clinic Foundation Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
| Ohio State University Coordinator of this site? Confirm its status | Columbus | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.